Table 1 Baseline characteristics of patients enrolled

Number

127

63

64

Age

55.94 ± 11.14

54.33 ± 11.74

57.52 ± 10.36

Male sex (%)

110 (86.6%)

58 (92.1%)

52 (81.2%)

BMI (kg/m²)

25.12 ± 2.61

25.48 ± 2.40

24.78 ± 2.78

Hypertension (%)

66 (52.0%)

32 (50.8%)

34 (53.1%)

T2DM (%)

51 (40.2%)

20 (31.7%)

31 (48.4%)

Current smoker (%)

87 (68.5%)

47 (74.6%)

40 (62.5%)

Killip classification

Class I

115 (90.6%)

55 (87.3%)

60 (93.8%)

Class II

10 (7.9%)

7 (11.1%)

3 (4.7%)

Class III

2 (1.6%)

1 (1.6%)

1 (1.6%)

Class IV

0

–

–

Baseline LVEF

49.98 ± 8.59

50.84 ± 9.41

49.13 ± 7.67

Laboratory examination

White blood cells (10⁹/L)

10.45 ± 2.47

10.35 ± 2.60

10.56 ± 2.35

Hemoglobin (g/L)

153.06 ± 12.96

152.89 ± 13.42

153.22 ± 12.59

Platelet (10⁹/L)

229.99 ± 63.95

232.79 ± 65.29

227.23 ± 62.99

eGFR (mmol/L)

99.86 ± 13.44

101.36 ± 14.27

98.38 ± 12.52

Uric acid (mg/dl)

357.22 ± 92.63

365.91 ± 106.52

348.66 ± 76.46

ABG (mmol/L)

8.38 (6.95,10.87)

6.99 (6.23,8.48)

10.10 (8.37,11.99)

HBA₁C (%)

6.00 (5.60,6.90)

6.00 (5.60,6.90)

6.00 (5.53,6.80)

SHR

1.22 ± 0.25

1.05 (0.95,1.11)

1.39 (1.28,1.50)

Triglycerides (mmol/L)

1.43 (1.00,1.97)

1.81 ± 1.13

1.36 (0.90,1.86)

LDL-C (mmol/L)

3.28 ± 1.06

3.23 ± 1.13

3.33 ± 0.98

HDL-C (mmol/L)

1.13 ± 0.28

1.06 ± 0.23

1.19 ± 0.31

Peak CK-MB

122.40 (45.10,258.00)

89.38 (26.60,202.60)

154.60 (54.18,299.00)

Peak cTnI (ng/ml)

30.62 (12.40,78.00)

20.62 (8.84,40.64)

56.07 (25.43,81.00)

Medications (Discharge)

Aspirin (%)

127 (100.0%)

63 (100.0%)

64 (100.0%)

Clopidogrel/ticagrelor (%)

127 (100.0%)

63 (100.0%)

64 (100.0%)

Statin (%)

123 (96.9%)

63 (100.0%)

60 (93.8%)

Beta-blockers (%)

109 (85.8%)

56 (88.9%)

53 (82.8%)

ACEI/ARB (%)

89 (70.1%)

43 (68.3%)

46 (71.9%)

Insulin (%)

7 (5.5%)

2 (3.2%)

5 (7.8%)

Hypoglycemic agents (%)

30 (23.6%)

13 (20.6%)

17 (26.6%)